No Ordinary Joe

It's been a year since consumer marketing master Joe Jimenez took over the top spot at Novartis Pharma. How's he faring?

The Total Customer Experience

Genentech had previously been number one by a very wide margin. This year, that margin started to narrow. Novartis is now a much closer second

The Buddy System

Jean-Marc Niemetz on forming partnerships with the industry's major stakeholders

Valuing Diversity

Veteran salesperson Reggie Smith of Genentech makes the case for sales force diversity

Study Rescue

Pharma companies must quit wasting money and get strategic when mapping out their clinical study strategies

Rights to Japan: Q&A with Steve Engen, Japan Bridge

Global marketing strategies and the business opportunities in Japan

Rethinking Vaccines: Q&A with Jane Quinn, GlaxoSmithKline

There are plenty of new vaccines on the market, but for patients to get maximum benefit from them, payers and even physicians need to rethink their roles in prevention.

Preemption Preview: Q&A with Mark Herrmann, Jones Day

Radio Active

David Barlow is the closest thing you can find to a pharma-industry ecologist. He takes companies that deal with technology that Big Pharma won't touch and turns them into drug powerhouses.